Japan’s Mitsubishi Chemical Group has resolved, at a meeting of the board of directors held today, to transfer its consolidated subsidiary, Mitsubishi Tanabe Pharma (MTPC), which engages in the ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.

Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

Shares in French cosmetics giant L'Oreal fell by more than 4% in early trade on Friday after the company posted its slowest ...

The trial of Alima Fall, nicknamed "Suppo", and her six co-defendants took place on Wednesday, February 5 at the Dakar court. The seven defendants are being prosecuted for endangering the lives of ...

The Local Content and Government Procurement Authority (LCGPA) announced on Feb. 6 the first batch of products eligible for ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 23,785.79 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...